Free Trial

National Research (NASDAQ:NRC) Announces Earnings Results

National Research logo with Business Services background

National Research (NASDAQ:NRC - Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.25 earnings per share for the quarter, Zacks reports. The business had revenue of $33.55 million for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Trading Up 5.5 %

Shares of NRC traded up $0.66 during mid-day trading on Friday, reaching $12.77. 97,269 shares of the company's stock traded hands, compared to its average volume of 95,056. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. The stock's 50-day moving average is $12.91 and its two-hundred day moving average is $16.28. National Research has a 12 month low of $9.76 and a 12 month high of $35.81. The stock has a market cap of $293.02 million, a P/E ratio of 12.16 and a beta of 0.34.

National Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 3.76%. The ex-dividend date of this dividend is Friday, June 27th. National Research's payout ratio is currently 46.60%.

National Research Company Profile

(Get Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Recommended Stories

Earnings History for National Research (NASDAQ:NRC)

Should You Invest $1,000 in National Research Right Now?

Before you consider National Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.

While National Research currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines